Evidence map›Paper›PMID 30127245›Full record

ArticleInternational journal of molecular sciences2018

In Vitro Inhibitory Mechanism Effect of TRAIP on the Function of TRAF2 Revealed by Characterization of Interaction Domains.

Eijaz Ahmed Bhat, Chang Min Kim, Sunghwan Kim, Hyun Ho Park

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Saudi journal of biological sciences · 2021
    Article
  2. Saudi journal of biological sciences · 2021
    Article
  3. Article
  4. Comparison of Target Recognition by TRAF1 and TRAF2.International journal of molecular sciences · 2020
    Article
  5. Roles of TRAFs in Ischemia-Reperfusion Injury.Frontiers in cell and developmental biology · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Eijaz Ahmed BhatDepartment of Chemistry and Biochemistry, School of Natural Science and Graduate School of Biochemistry at Yeungnam University, Gyeongsan 38541, Korea. eijazbhat05@gmail.com.ORCID 0000-0002-0372-1511
Chang Min KimCollege of Pharmacy, Chung-Ang University, Seoul 06974, Korea. 6427372@naver.com.
Sunghwan KimNew Drug Development Center, Daegu-Gyeongbuk Medical Innovation Foundation, Daegu 41061, Korea. sunghwan.kim@polus-global.com.
Hyun Ho ParkCollege of Pharmacy, Chung-Ang University, Seoul 06974, Korea. xrayleox@cau.ac.kr.ORCID 0000-0001-9928-0847
Chung-Ang University · KRDaegu-Gyeongbuk Medical Innovation Foundation · KRYeungnam University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

TRAF-interacting protein (TRAIP), a negative regulator of TNF-induced-nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) activation, inhibits adaptor protein TRAF2 by direct interaction and is critical in apoptosis, cell proliferation, antiviral response, and embryonic development. Although the critical function of TRAIP in NF-κB signaling is well-known, the molecular inhibitory mechanism of TRAIP remains unclear. We found that the TRAIP coiled-coil domain altered its stoichiometry between dimer and trimer in a concentration-dependent manner. Additionally, the TRAIP RING domain induced even higher-ordered assembly, which was necessary for interacting with the TRAF-N domain of TRAF2 but not TRAF1. Characterization of the TRAF-N domains of TRAF1 and TRAF2, the tentative TRAIP-binding region of TRAFs, suggested the molecular basis of the inhibitory effect of TRAIP on TRAF2 in NF-κB signaling.

Indexed as

HumansProtein BindingProtein Interaction Domains and MotifsProtein Interaction MapsProtein MultimerizationProtein StabilityTNF Receptor-Associated Factor 2Tumor Necrosis Factor Receptor-Associated Peptides and ProteinsTNF Receptor-Associated Factor 2Tumor Necrosis Factor Receptor-Associated Peptides and Proteinsimmune responsenuclear factor-κBprotein interactionTRAF-interacting proteintumor necrosis factor-receptor associated factor

Identifiers

PMID30127245
PMCPMC6121587
OpenAlexW2886269821

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.